Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
about
Race, healthcare access and physician trust among prostate cancer patientsClinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort studyMultilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.Treatment decisions for localized prostate cancer: a concept mapping approachBarriers to planning and conducting a screening: prostate cancer.Racial Healthcare Disparities: A Social Psychological Analysis.Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.Factors associated with time-to-treatment of prostate cancer in Florida.Usability evaluation and adaptation of the e-health Personal Patient Profile-Prostate decision aid for Spanish-speaking Latino menComorbid disease and cancer: the need for more relevant conceptual models in health services researchCancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.Trends in prostate cancer in the United States.Health disparities in staging of SEER-medicare prostate cancer patients in the United States.Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis.Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007.Life-Threatening Disparities: The Treatment of Black and White Cancer Patients.Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer.Prostate cancer epidemiology in the United States.Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center.Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey.Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancerCancer patients' perceptions regarding the value of the physical examination: a survey study.Explaining racial differences in prostate cancer mortality.African American men significantly underestimate their risk of having prostate cancer at the time of biopsy.Racial disparities and considerations for active surveillance of prostate cancer.
P2860
Q33610509-FC21FF2A-4056-4938-8A2E-4DB294B07802Q33630790-B7795C91-DBF1-475C-A076-038869084953Q33693397-A06DE053-180F-4BE8-A0D3-674281AEDA70Q34028603-93D22900-A00F-48C1-AD33-C20C16BBB1AEQ34041005-D6908EB9-BA03-4650-A4C8-7B6737844968Q34118744-0B7A8291-AD79-403B-91F7-86A820B8BACDQ34872970-0FE75895-18EF-427D-A74C-75EA7F2B4E4DQ35111947-14936A11-654B-43F7-AA04-11925BE28E62Q35708674-448B8E3E-7470-4682-B351-E17326C7079FQ35753982-EFC82F93-C444-467F-8D0F-A1DBC5AEDA87Q35955484-EFE816DA-05AD-47F4-96EE-A71A68DAB95CQ36421159-91105E60-9891-4143-A7E2-A09EB07053D1Q36520517-888C4F5E-F738-47FB-988C-E70F0A11E6C0Q37078086-2E6D8ADA-294D-45C0-B8C6-DB462E3F6E1AQ37152796-AFEF564A-878C-4A59-ADD6-00CB33660C7EQ37161492-A4CCAC0E-86CB-44E1-AB32-6E58A580820CQ37361918-1389E7AB-CA1B-4ABE-99BC-9D8470303FF8Q37426733-97E3E807-91EC-4174-AFD9-9721E8DB583CQ38000053-EF1E6415-E222-40DB-9283-D55A1C219E73Q38052332-08A4CE34-7D07-4776-ABBC-A7DE9D3DE91EQ38391188-5CCCC632-31E5-453F-A53F-4778747BEFEAQ40162804-B3192736-6BAB-4D47-8CFE-E8B558DF01B2Q40566372-1E35D294-BBB9-43C2-8B9A-A5A642007F3EQ41404755-D3CEAFF9-5349-4638-8462-0D43431AC9FBQ45132636-8EE32836-73D5-4550-8F52-03AD77829404Q46526838-5D3548F5-579F-4C43-BED4-3B39264D02A1Q46586239-33F67E4B-78A4-4C89-A9BC-C528C9B81850Q55360389-BCEE9C33-B62E-415A-872E-81EA3F44624B
P2860
Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Race/ethnicity and the intensi ...... waiting' for prostate cancer.
@en
Race/ethnicity and the intensi ...... waiting' for prostate cancer.
@nl
type
label
Race/ethnicity and the intensi ...... waiting' for prostate cancer.
@en
Race/ethnicity and the intensi ...... waiting' for prostate cancer.
@nl
prefLabel
Race/ethnicity and the intensi ...... waiting' for prostate cancer.
@en
Race/ethnicity and the intensi ...... waiting' for prostate cancer.
@nl
P2093
P1433
P1476
Race/ethnicity and the intensi ...... waiting' for prostate cancer.
@en
P2093
Angela Fahey
Arnold L Potosky
Carrie N Klabunde
Martin Brown
Vickie L Shavers
William Davis
P304
P356
10.1097/01.MLR.0000117361.61444.71
P577
2004-03-01T00:00:00Z